Press release
Radiopharmaceutical Theranostics Global Market 2023 - Industry Analysis, Size, Share, Growth, Trends And Forecast To 2032
Radiopharmaceutical Theranostics Market
The Business Research Company's Radiopharmaceutical Theranostics Global Market Report 2023 identifies xrising incidence of cancer as the major driver for the Radiopharmaceutical Theranostics market's growth in the forecast period. Cancer refers to a disease or condition of complex and abnormal growth of cells that can invade and spread to other parts of the body. Radiopharmaceutical theranostics helps in cancer treatment by providing targeted and personalized approaches.
The global radiopharmaceutical theranostics market size is expected to grow from $2.21 billion in 2022 to $2.51 billion in 2023 at a compound annual growth rate (CAGR) of 13.63%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of radiopharmaceutical theranostics market is expected to reach $4.25 billion in 2027 at a CAGR of 14.11%.
Download Free Sample Of Radiopharmaceutical Theranostics Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=11951&type=smp
Major competitors in the Radiopharmaceutical Theranostics market are Cardinal Health Inc., AstraZeneca Plc, GE HealthCare Technologies Inc., Bayer AG.
A key trend in the Radiopharmaceutical Theranostics market includes technological advancements. Major companies operating in the radiopharmaceutical theranostics market are developing advanced technologies to sustain their position in the market. For instance, in March 2021, GE HealthCare Technologies Inc., a US-based medical technology company, launched StarGuide, its latest SPECT/CT technology, aimed at helping advance precision health and theranostics. This advanced system incorporates the latest Cadmium Zinc Telluride (CZT) technology, which enables healthcare providers to gain deeper insights into patient conditions and improve patient outcomes across various care areas.
Read More On The Global Radiopharmaceutical Theranostics Market Report Here:
https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-theranostics-global-market-report
The Radiopharmaceutical Theranostics market is segmented -
• By Product Type: Alpha Emitters, Beta Emitters, Positron Emission Tomography (PET) Tracers
• By Source: Nuclear Reactors, Cyclotrons
• By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, 18F, Y-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioscopes
• By Indication: Oncology, Cardiology, Neurology, Other Indications
• By End User: Hospitals, Diagnostic Imaging Centers, Academic And Research Institutes, Other End Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Radiopharmaceutical Theranostics market.
The Business Research Company's "Global Radiopharmaceutical Theranostics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Radiopharmaceutical Theranostics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11951
The Table Of Content For The Radiopharmaceutical Theranostics Market Include:
1. Executive Summary
2. Radiopharmaceutical Theranostics Market Characteristics
3. Radiopharmaceutical Theranostics Market Trends And Strategies
4. Radiopharmaceutical Theranostics Market - Macro Economic Scenario
5. Global Radiopharmaceutical Theranostics Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
……………………………….
32. Global Radiopharmaceutical Theranostics Market Competitive Benchmarking
33. Global Radiopharmaceutical Theranostics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Radiopharmaceutical Theranostics Market
35. Radiopharmaceutical Theranostics Market Future Outlook and Potential Analysis
36. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceutical Theranostics Global Market 2023 - Industry Analysis, Size, Share, Growth, Trends And Forecast To 2032 here
News-ID: 3218087 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Radiopharmaceutical
Radiopharmaceutical Preclinical CRO Market Dynamics Shaped by Increasing Focus o …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radiopharmaceutical Preclinical CRO Market Size, Share & Trends Analysis Report By Organization Size (Small and Medium Enterprises (SMEs), Large Pharmaceutical Corporations), Radiopharmaceutical Types (PET Tracers, SPECT Tracers, Therapeutic Radiopharmaceuticals), Services (Safety Assessment, Bioanalytical Testing, Dose Formulation, Regulatory Affairs Support) Therapeutic Area (Oncology, Cardiology, Neurology), End-Users (Pharmaceutical Companies, Biotechnology Firms, Academic Research Institutions, Government Organizations)- Market…
Radiopharmaceutical/Nuclear Medicine Market Size and Trends
The radiopharmaceutical/nuclear medicine market is poised for significant expansion in the coming years. With advancements in technology, increasing disease prevalence, and a growing emphasis on personalized medicine, the market presents lucrative opportunities for stakeholders. As the healthcare landscape evolves, the integration of innovative radiopharmaceuticals into clinical practice will continue to enhance diagnostic and therapeutic outcomes, ultimately improving patient care.
The key players in the radiopharmaceutical/nuclear medicine market include Eckert & Ziegler,…
Radiopharmaceutical Market 2021 | Detailed Report
Radiopharmaceutical Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Radiopharmaceutical Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4123322
The report provides a comprehensive analysis of company profiles listed below:
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
-…
Impressive Trends and Future Scope of Radiopharmaceutical Market
Radiopharmaceutical Market: Introduction
According to the report, the global radiopharmaceutical market was valued at US$ 3.6 Bn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027. Some of the factors driving the radiopharmaceutical market are expansion activities of key radiopharma players; applications in clinical trials; and increase in aging population, pipeline assessment of new drugs, and disease indication mortality. Shutdown of some of the…
Radiopharmaceutical Market Development Status and Outlook 2024
Radiopharmaceutical Market: Snapshot
The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological disorders, and cardiovascular diseases. Around 35 million patients undergo treatment procedures for these diseases each year and this will continue to boost the demand for radiopharmaceuticals.
Read Report Overview for Radiopharmaceutical Market: http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html
According to the…
Competition Landscape for Radiopharmaceutical Market Global Industry 2024
The global radiopharmaceutical market was valued at US$4.7 bn in 2015 and is estimated to reach US$7.4 bn by 2024, expanding at a CAGR of 5.3% from 2016 to 2024.
Download Exclusive Global Strategic Business Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=213
Radiopharmaceutical Market: Snapshot
The global market for radiopharmaceuticals is poised for steady growth in the coming years, driven primarily by the rising use of radioisotopes for the treatment of various diseases, such as cancer, bone palliation, neurological…
